•  
  •  
  •  
  •  

2025-10-08 08:04:19

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • ppeks
  • koesss
  • kentosss
  • kentosss
  • kentosss

Keywords Selected:  Pharma

Research

  • Anand Rathi Report: India Pharma - Healthy growth in Dec'22; volumes slow down
  • Quant Thematic - Three factor model for stocks filtration
  • Aurobindo Pharma - Entry into India - a little too late?
  • Natco Pharma - Natco and Teva launch Revlimid in the US - ICICI Securities

Stock Report

  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Wockhardt Submits New Drug Application to U.S. FDA for Zidebactam-Cefepime for Treatment of Serious GramNegative Infections
  • Glenmark Strengthens Oncology Portfolio with Hengrui's HER2 Targeting ADC For Multiple Regions
  • Relonchem Limited receives Marketing Authorization for its products
  • Shelter Pharma's Participation in AYUSH India Expo 2025
  • Shelter Pharma Ltd installs 15 KW solar power plant
  • Fire Incident at APL Healthcare Ltd's Unit 4 at Naidupeta
  • CuraTeQ Biologics Pvt Ltd completes Phase 3 Clinical Study for Denosumab Biosimilar
  • NATCO Pharma Ltd updates on acquisition of Adcock Ingram
  • Apitoria Pharma Pvt Ltd receives 5 observations from USFDA for API facility
  • Gland Pharma receives approval for Vasopressin in 5% Dextrose RTU Injection
  • CuraTeQ Biologics receives approval for biosimilar Dazublys from UK's MHRA
  • Shelter Pharma Ltd receives new order
  • Crisil ESG Ratings & Analytics Ltd assigns Crisil ESG 57 rating to Mankind Pharma Limited
  • Piramal Pharma Solutions and NewAmsterdam Pharma announce dedicated OSD production Capabilities at Piramal's Sellersville, Pennsylvania Site
  • NATCO launches Bosentan Tablets for Oral Suspension in the United States with 180-day exclusivity
  • Relonchem Limited receives Marketing Authorization for its products
  • Gland Pharma receives approval for Norepinephrine Bitartrate in 5% Dextrose Injection Bags
  • Gland Pharma receives approval from USFDA for Cangrelor for Injection 50 mg/vial
  • Bliss GVS Pharma Ltd Q1 FY2026 consolidated net profit surges to Rs. 43.03 crores
  • Piramal Pharma Ltd Q1 FY2025-26 consolidated loss at Rs. 81.70 crores
  • Ajanta Pharma Ltd consolidated Q1FY26 PAT up at Rs. 255.34 crores
  • Anuh Pharma Ltd allots 5,01,12,000 fully paid-up Bonus Equity Shares
  • Anuh Pharma Ltd inaugurates new manufacturing block

Latest Post

  • ppeks
  • koesss
  • kentosss
  • kentosss
  • kentosss


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024